You can:
Name | Adenosine receptor A1 |
---|---|
Species | Homo sapiens (Human) |
Gene | ADORA1 |
Synonym | RDC7 A1 receptor A1-AR A1R adenosine receptor A1 |
Disease | Cardiac arrhythmias Hypertension Cardiac disease Cognitive disorders Diabetes [ Show all ] |
Length | 326 |
Amino acid sequence | MPPSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFCFIVSLAVADVAVGALVIPLAILINIGPQTYFHTCLMVACPVLILTQSSILALLAIAVDRYLRVKIPLRYKMVVTPRRAAVAIAGCWILSFVVGLTPMFGWNNLSAVERAWAANGSMGEPVIKCEFEKVISMEYMVYFNFFVWVLPPLLLMVLIYLEVFYLIRKQLNKKVSASSGDPQKYYGKELKIAKSLALILFLFALSWLPLHILNCITLFCPSCHKPSILTYIAIFLTHGNSAMNPIVYAFRIQKFRVTFLKIWNDHFRCQPAPPIDEDLPEERPDD |
UniProt | P30542 |
Protein Data Bank | 6d9h, 5n2s |
GPCR-HGmod model | P30542 |
3D structure model | This structure is from PDB ID 6d9h. |
BioLiP | BL0385576, BL0417675 |
Therapeutic Target Database | T88714, T92072 |
ChEMBL | CHEMBL226 |
IUPHAR | 18 |
DrugBank | BE0000013 |
Name | ST-1535 |
---|---|
Molecular formula | C12H16N8 |
IUPAC name | 2-butyl-9-methyl-8-(triazol-2-yl)purin-6-amine |
Molecular weight | 272.316 |
Hydrogen bond acceptor | 6 |
Hydrogen bond donor | 1 |
XlogP | 1.8 |
Synonyms | CTK1D0597 AKOS030562134 GTPL5613 2-butyl-9-methyl-8-(2H-1,2,3-triazol-2-yl)-9H-purin-6-amine 2-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine [ Show all ] |
Inchi Key | CYYQMAWUIRPCNW-UHFFFAOYSA-N |
Inchi ID | InChI=1S/C12H16N8/c1-3-4-5-8-16-10(13)9-11(17-8)19(2)12(18-9)20-14-6-7-15-20/h6-7H,3-5H2,1-2H3,(H2,13,16,17) |
PubChem CID | 9860294 |
ChEMBL | CHEMBL197669 |
IUPHAR | 5613 |
BindingDB | 50176058 |
DrugBank | N/A |
Structure | ![]() |
Lipinski's druglikeness | This ligand satisfies Lipinski's rule of five. |
Parameter | Value | Reference | Database source |
---|---|---|---|
Ki | 71.8 nM | PMID23602401, PMID16250647 | IUPHAR,ChEMBL |
Ki | 72.0 nM | PMID16250647 | BindingDB |
Ki | 79.0 nM | PMID24164628 | BindingDB |
Ki | 79.2 nM | PMID24164628 | ChEMBL |
Ki | 100.0 nM | PMID23789814 | ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417